Quantitative Pulmonary Imaging Registry & Biorepository
PIBR
PIBR
Sponsor study identifier
observational
100
1 country
1
Study Start
May 24, 2022
Actual (reported)Primary Completion
December 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
May 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological significance of imaging biomarkers. This registry and biorepository will accelerate the development of these imaging techniques and may lead toward future clinical adoption of quantitative pulmonary imaging.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 24, 2022
Actual (reported)September 2, 2022
Actual (reported)September 7, 2022
Actual (reported)December 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
May 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Collect Clinical Data
Collect relevant medical history (including demographic information, diagnoses, medical tests, smoking history), for patients participating in pulmonary imaging research.
From Enrollment to 3 Months
Establish a Biorepository
Establish a collection of biospecimens from imaging subjects to foster an improved understanding of the physiological significance of imaging biomarkers.
From Enrollment to 3 Months
Biospecimen Collection
Correlate imaging biomarkers with biospecimens and physiological/vital signs data.
From Enrollment to 6 Months
Collaborate
Provide images and biospecimens to researchers working to develop analysis methods for pulmonary CT and MRI. Separate IRB approval, alongside appropriate data and/or materials transfer agreements will be needed for these studies.
From Enrollment to 12 Months
Participating in an Imaging Study at KUMC
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Peter J Niedbalski, PhD
Research Assistant Professor
Luigi R Boccardi, MPH
Director of Pulmonary, Critical Care, & Sleep Research
First Submitted
September 2, 2022
First Posted
September 7, 2022
Study Start
May 24, 2022
Actual (reported)Primary Completion
December 31, 2027
EstimatedDECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
May 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
May 6, 2026
Record last verified: 2026-04
Collaborators at KUMC that are not on the study team may request access to identified or deidentified data/biospecimens from this project. Collaborators may include parties outside of KUMC, in which case only deidentified data will be shared. When potential collaborators request access to data and/or biospecimens, the following will be considered: research question and study design, timing of request, and amount of specimen needed. Corporate entities will not be allowed access to data or samples from the biobank.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: